Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.

Ladd JJ, Chao T, Johnson MM, Qiu J, Chin A, Israel R, Pitteri SJ, Mao J, Wu M, Amon LM, McIntosh M, Li C, Prentice R, Disis N, Hanash S.

Cancer Res. 2013 Mar 1;73(5):1502-13. doi: 10.1158/0008-5472.CAN-12-2560. Epub 2012 Dec 26.

2.

An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis.

Katayama H, Boldt C, Ladd JJ, Johnson MM, Chao T, Capello M, Suo J, Mao J, Manson JE, Prentice R, Esteva F, Wang H, Disis ML, Hanash S.

Cancer Res. 2015 Aug 15;75(16):3246-54. doi: 10.1158/0008-5472.CAN-15-0248. Epub 2015 Jun 18.

3.

Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.

Mao J, Ladd J, Gad E, Rastetter L, Johnson MM, Marzbani E, Childs JS, Lu H, Dang Y, Broussard E, Stanton SE, Hanash SM, Disis ML.

J Transl Med. 2014 May 10;12:121. doi: 10.1186/1479-5876-12-121.

4.

Autoantibody profiles as biomarkers of breast cancer.

Tabernero MD, Lv LL, Anderson KS.

Cancer Biomark. 2010;6(5-6):247-56. doi: 10.3233/CBM-2009-0139. Review.

PMID:
20938085
5.

Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.

Evans RL, Pottala JV, Egland KA.

Cancer Prev Res (Phila). 2014 May;7(5):545-55. doi: 10.1158/1940-6207.CAPR-13-0416. Epub 2014 Mar 18.

6.

Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.

Lacombe J, Mangé A, Jarlier M, Bascoul-Mollevi C, Rouanet P, Lamy PJ, Maudelonde T, Solassol J.

Int J Cancer. 2013 Mar 1;132(5):1105-13. doi: 10.1002/ijc.27766. Epub 2012 Aug 28.

7.

Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer.

Anderson KS, Ramachandran N, Wong J, Raphael JV, Hainsworth E, Demirkan G, Cramer D, Aronzon D, Hodi FS, Harris L, Logvinenko T, LaBaer J.

J Proteome Res. 2008 Apr;7(4):1490-9. doi: 10.1021/pr700804c. Epub 2008 Feb 27.

8.
9.

Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients.

Hamsher C, Smith AM, Dehqanzada ZA, Khoo S, Ponniah S, Peoples GE, Moroni M.

Cancer Immunol Immunother. 2007 Nov;56(11):1711-21. Epub 2007 Apr 18.

PMID:
17440722
10.

Autoantibodies in breast cancer: their use as an aid to early diagnosis.

Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, Barnes A, Robertson J.

Ann Oncol. 2007 May;18(5):868-73. Epub 2007 Mar 7.

PMID:
17347129
11.

A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers.

Grandjean M, Dieu M, Raes M, Feron O.

J Immunol Methods. 2013 Oct 31;396(1-2):23-32. doi: 10.1016/j.jim.2013.07.006. Epub 2013 Aug 2.

PMID:
23916966
12.

Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.

Abols A, Ducena K, Zayakin P, Silina K, Kalnina Z, Sadovska L, Tars J, Vilmanis J, Narbuts Z, Eglitis J, Pirags V, Line A.

Cancer Biomark. 2014;14(5):361-9. doi: 10.3233/CBM-140413.

PMID:
25171478
13.

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.

Madoz-Gúrpide J, Kuick R, Wang H, Misek DE, Hanash SM.

Mol Cell Proteomics. 2008 Feb;7(2):268-81. Epub 2007 Oct 4.

14.

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.

Stockert E, Jäger E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ.

J Exp Med. 1998 Apr 20;187(8):1349-54.

15.

Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers.

Ummanni R, Duscharla D, Barett C, Venz S, Schlomm T, Heinzer H, Walther R, Bokemeyer C, Brümmendorf TH, Murthy PV, Balabanov S.

J Proteomics. 2015 Apr 24;119:218-29. doi: 10.1016/j.jprot.2015.02.005. Epub 2015 Feb 24.

PMID:
25724726
16.

Development of a novel, quantitative protein microarray platform for the multiplexed serological analysis of autoantibodies to cancer-testis antigens.

Beeton-Kempen N, Duarte J, Shoko A, Serufuri JM, John T, Cebon J, Blackburn J.

Int J Cancer. 2014 Oct 15;135(8):1842-51. doi: 10.1002/ijc.28832. Epub 2014 Mar 24.

17.

Autoantibodies as potential biomarkers for breast cancer.

Zhong L, Ge K, Zu JC, Zhao LH, Shen WK, Wang JF, Zhang XG, Gao X, Hu W, Yen Y, Kernstine KH.

Breast Cancer Res. 2008;10(3):R40. doi: 10.1186/bcr2091. Epub 2008 May 7.

18.

Autoantibody biomarker opens a new gateway for cancer diagnosis.

Nesterova M, Johnson N, Cheadle C, Cho-Chung YS.

Biochim Biophys Acta. 2006 Apr;1762(4):398-403. Epub 2006 Jan 30.

19.

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.

Blixt O, Bueti D, Burford B, Allen D, Julien S, Hollingsworth M, Gammerman A, Fentiman I, Taylor-Papadimitriou J, Burchell JM.

Breast Cancer Res. 2011 Mar 8;13(2):R25. doi: 10.1186/bcr2841.

20.

Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.

Dorvillius M, Garambois V, Pourquier D, Gutowski M, Rouanet P, Mani JC, Pugnière M, Hynes NE, Pèlegrin A.

Tumour Biol. 2002 Nov-Dec;23(6):337-47.

PMID:
12677091

Supplemental Content

Support Center